EVC, or Ellis-van Creveld syndrome protein, is a crucial component of the primary cilium, a cellular organelle that acts as a signaling hub for various pathways, including the Hedgehog (Hh) pathway. The EVC gene, along with its related gene EVC2, is implicated in the rare genetic disorder Ellis-van Creveld syndrome (EvC), characterized by short stature, polydactyly, heart defects, and distinctive facial features.The EVC protein is involved in the transduction of the Hh signaling pathway, which is essential for patterning and growth during embryonic development. It is particularly important in the development of bones and teeth. The Hh pathway, when activated, drives the expression of target genes that govern cell fate, growth, and differentiation.
Mutations in the EVC gene disrupt the normal function of the protein, leading to the spectrum of abnormalities seen in EvC syndrome. These mutations can affect the structure or amount of EVC protein, impairing its role in the Hh pathway and resulting in the improper development of various tissues, particularly affecting chondrocytes in the growth plate of bones.Research on EVC has provided insights into the broader implications of primary cilia in human disease. Beyond EvC syndrome, dysfunction in ciliary proteins is linked to a class of diseases known as ciliopathies, which can affect multiple organ systems.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine inhibits the Hh signaling pathway, which may compensate by upregulating EVC expression to maintain pathway activity. | ||||||
Purmorphamine | 483367-10-8 | sc-202785 sc-202785A | 1 mg 5 mg | $57.00 $184.00 | 18 | |
Purmorphamine activates the Hh pathway, potentially increasing EVC expression as part of the pathway activation. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3, through its receptor, can modulate gene expression and may influence EVC expression during bone development. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression during embryonic development and could regulate EVC expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a DNA methyltransferase inhibitor, it may demethylate the EVC gene promoter, leading to increased expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that could increase histone acetylation and activate EVC expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is an HDAC inhibitor that may enhance EVC expression by altering chromatin structure. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can activate Wnt signaling, which may intersect with Hh pathway regulation of EVC expression. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
Folic acid is crucial for proper DNA methylation and gene expression, potentially affecting EVC expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG may modulate epigenetic marks and influence EVC expression in development. | ||||||